Differentiated thyroid cancer incidentally detected by 18F-FDG PET/CT: patient’s future in a hot-spot? Silvia MorbelliMarcello Bagnasco Editorial Commentary 14 May 2014 Pages: 1479 - 1481
18F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study Arnoldo PiccardoMatteo PuntoniLuca Giovanella Original Article 30 April 2014 Pages: 1482 - 1491
Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT Sandip BasuBhawna SirohiShailesh V. Shrikhande Editorial 27 May 2014 Pages: 1492 - 1496
Thyroid nodules with indeterminate cytology: molecular imaging with 99mTc-methoxyisobutylisonitrile (MIBI) is more cost-effective than the Afirma® gene expression classifier Alexander HeinzelDirk MüllerFrederik A. Verburg Short Communication 05 April 2014 Pages: 1497 - 1500
18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma Pierre-Yves SalaunLoïc CampionFrançoise Kraeber-Bodéré Original Article 08 May 2014 Pages: 1501 - 1510
MRI and 18F-FDG PET/CT in monitoring the response to neoadjuvant chemotherapy: is it necessary to appropriately select the patients? Laura EvangelistaDomenico RuggieriGiorgio Saladini Editorial Commentary 05 June 2014 Pages: 1511 - 1514
Combined use of 18F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy Kenneth E. PengelBas B. KoolenKenneth G. A. Gilhuijs Original Article 29 April 2014 Pages: 1515 - 1524
HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy Olivier HumbertAlexandre CochetFrançois Brunotte Original Article 20 March 2014 Pages: 1525 - 1533
Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from 68Ga-RGD PET/CT and 18F-FDG PET/CT Hai-Jeon YoonKeon Wook KangWoo Kyung Moon Original Article 21 March 2014 Pages: 1534 - 1543
A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy Stéphanie Servagi-VernatSarah DifferdingVincent Grégoire Original Article 26 February 2014 Pages: 1544 - 1552
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18 F-FDG PET/CT and MRI Byung Hyun ByunChang-Bae KongSang Moo Lim Original Article 21 March 2014 Pages: 1553 - 1562
Integrated 18F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology Michael A. FischerBart VrugtPatrick Veit-Haibach Original Article 24 April 2014 Pages: 1563 - 1573
Comparison of MR-based attenuation correction and CT-based attenuation correction of whole-body PET/MR imaging David Izquierdo-GarciaStephen J. SawiakZahi A. Fayad Original Article 21 March 2014 Pages: 1574 - 1584
Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network Karin HohlochH. K. LankeitL. Trümper Original Article 11 April 2014 Pages: 1585 - 1592
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer Rafke SchoffelenWietske Woliner-van der WegOtto C. Boerman Original Article 19 March 2014 Pages: 1593 - 1602
Bispecific antibody complex pre-targeting and targeted delivery of polymer drug conjugates for imaging and therapy in dual human mammary cancer xenografts Ban-An KhawKeyur S. GadaAndrew Weisenberger Original Article 19 March 2014 Pages: 1603 - 1616
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study Maddalena GraziosiCristina NanniClaudio Rapezzi Original Article 07 May 2014 Pages: 1617 - 1623
Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study Jingjing ZhangHua ChenZhaohui Zhu Original Article Open access 25 April 2014 Pages: 1624 - 1634
New EANM paediatric dosage card: optimization of F-18 FDG-administered activities Gilles MetrardHélène BesseSabine Gauvain Letter to the Editor 04 June 2014 Pages: 1635 - 1635
Pediatric Radiopharmaceutical Administration: Harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the 2010 North American Consensus guideline Michael LassmannS. Ted Treves Letter to the Editor 04 June 2014 Pages: 1636 - 1636
Angelina Cistaro (ed): Atlas of PET/CT in Pediatric Patients Luigi Mansi Book Review 17 April 2014 Pages: 1637 - 1638
Hojjat Ahmadzadehfar and Hans-Jürgen Biersack (Eds): Clinical Applications of SPECT-CT Sara M.d.A. GiorgioLuigi Mansi Book Review 15 May 2014 Pages: 1639 - 1639
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis Swen HesseFranziska MoellerOsama Sabri Erratum 15 May 2014 Pages: 1640 - 1641
Transposed ovary mimicking a peritoneal implant on FDG PET/CT in a patient with carcinoma of the rectum Kanhaiyalal AgrawalRakesh S. SajjanRizwan Syed Image of the Month 17 April 2014 Pages: 1642 - 1643
Injection artefact displaying “sock” pattern on bone scan: “glove” sign equivalent resulting from bisphosphonate-(99mTc) injection in foot venous system F. GiammarileT. MognettiF. Paycha Image of the Month 28 May 2014 Pages: 1644 - 1645
Nuclear medicine training and practice in the Czech Republic Milan KamínekPavel Koranda UEMS/EBNM 28 May 2014 Pages: 1646 - 1647
